120 related articles for article (PubMed ID: 38365441)
1. Deficient Generation of Spike-Specific Long-Lived Plasma Cells in the Bone Marrow After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Tehrani ZR; Habibzadeh P; Flinko R; Chen H; Abbasi A; Yared JA; Ciupe SM; Lewis GK; Sajadi MM
J Infect Dis; 2024 Feb; ():. PubMed ID: 38365441
[TBL] [Abstract][Full Text] [Related]
2. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates.
Prabhakaran M; Matassoli F; Leggat D; Hoover A; Srikanth A; Wu W; Henry AR; Wang J; Lin BC; Teng IT; Schramm CA; Castro M; Serebryannyy L; Jean-Baptiste N; Moore C; Gajjala S; Todd JM; McCarthy E; Narpala S; Francica J; Program VP; Corbett-Helaire KS; Douek DC; Kwong PD; Seder RA; Andrews SF; McDermott AB
Sci Transl Med; 2024 Jan; 16(728):eadd5960. PubMed ID: 38170789
[TBL] [Abstract][Full Text] [Related]
3. Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.
Epsi NJ; Richard SA; Lindholm DA; Mende K; Ganesan A; Huprikar N; Lalani T; Fries AC; Maves RC; Colombo RE; Larson DT; Smith A; Chi SW; Maldonado CJ; Ewers EC; Jones MU; Berjohn CM; Libraty DH; Edwards MS; English C; Rozman JS; Mody RM; Colombo CJ; Samuels EC; Nwachukwu P; Tso MS; Scher AI; Byrne C; Rusiecki J; Simons MP; Tribble D; Broder CC; Agan BK; Burgess TH; Laing ED; Pollett SD;
Clin Infect Dis; 2023 Feb; 76(3):e439-e449. PubMed ID: 35608504
[TBL] [Abstract][Full Text] [Related]
4. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
5. Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
Upasani V; Townsend K; Wu MY; Carr EJ; Hobbs A; Dowgier G; Ragno M; Herman LS; Sharma S; Shah D; Lee SFK; Chauhan N; Glanville JM; Neave L; Hanson S; Ravichandran S; Tynan A; O'Sullivan M; Moreira F; Workman S; Symes A; Burns SO; Tadros S; Hart JCL; Beale RCL; Gandhi S; Wall EC; McCoy L; Lowe DM
Clin Infect Dis; 2023 Oct; 77(7):950-960. PubMed ID: 37338118
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC; Lamothe PA; Woodruff MC; Saini AS; Faliti CE; Sanz I; Lee FE
Immunol Rev; 2022 Aug; 309(1):40-63. PubMed ID: 35801537
[TBL] [Abstract][Full Text] [Related]
7. Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue.
Mahallawi WH; Aljeraisi TM
Clin Immunol; 2021 Oct; 231():108850. PubMed ID: 34506944
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.
Turner JS; Kim W; Kalaidina E; Goss CW; Rauseo AM; Schmitz AJ; Hansen L; Haile A; Klebert MK; Pusic I; O'Halloran JA; Presti RM; Ellebedy AH
Res Sq; 2020 Dec; ():. PubMed ID: 33398264
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.
Turner JS; Kim W; Kalaidina E; Goss CW; Rauseo AM; Schmitz AJ; Hansen L; Haile A; Klebert MK; Pusic I; O'Halloran JA; Presti RM; Ellebedy AH
Nature; 2021 Jul; 595(7867):421-425. PubMed ID: 34030176
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand.
Poolchanuan P; Matsee W; Sengyee S; Siripoon T; Dulsuk A; Phunpang R; Pisutsan P; Piyaphanee W; Luvira V; Chantratita N
mSphere; 2023 Feb; 8(1):e0046522. PubMed ID: 36688637
[TBL] [Abstract][Full Text] [Related]
11. Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination.
Haralambieva IH; Monroe JM; Ovsyannikova IG; Grill DE; Poland GA; Kennedy RB
J Infect Dis; 2022 Aug; 226(1):23-31. PubMed ID: 35137144
[TBL] [Abstract][Full Text] [Related]
12. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 specific plasma cells acquire long-lived phenotypes in human bone marrow.
Schulz AR; Fiebig L; Hirseland H; Diekmann LM; Reinke S; Hardt S; Niedobitek A; Mei HE
EBioMedicine; 2023 Sep; 95():104735. PubMed ID: 37556944
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow derived long-lived plasma cell phenotypes are heterogeneous and can change in culture.
Mujtahedi SS; Yigitbilek F; Benavides X; Merzkani MA; Ozdogan E; Abozied O; Moore NA; Park WD; Stegall MD
Transpl Immunol; 2022 Dec; 75():101726. PubMed ID: 36183942
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab.
Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
Int J Urol; 2022 Nov; 29(11):1279-1286. PubMed ID: 35863901
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
[TBL] [Abstract][Full Text] [Related]
17. A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
Martinuzzi E; Benzaquen J; Guerin O; Leroy S; Simon T; Ilie M; Hofman V; Allegra M; Tanga V; Michel E; Boutros J; Maniel C; Sicard A; Glaichenhaus N; Czerkinsky C; Blancou P; Hofman P; Marquette CH
Clin Infect Dis; 2022 Dec; 75(12):2053-2059. PubMed ID: 35579991
[TBL] [Abstract][Full Text] [Related]
18. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
Hu H; Lu X; Tao L; Bai B; Zhang Z; Chen Y; Zheng F; Chen J; Chen Z; Wang H
Clin Vaccine Immunol; 2007 Jul; 14(7):894-901. PubMed ID: 17494640
[TBL] [Abstract][Full Text] [Related]
19. Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study.
Breznik JA; Rahim A; Bhakta H; Clare R; Zhang A; Ang J; Stacey HD; Liu LM; Kennedy A; Bilaver L; Hagerman M; Kajaks T; Bramson JL; Nazy I; Miller MS; Costa AP; Bowdish DME;
J Med Virol; 2023 Oct; 95(10):e29170. PubMed ID: 37822054
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy alters interleukin-1 beta expression and antiviral antibody responses during severe acute respiratory syndrome coronavirus 2 infection.
Sherer ML; Lei J; Creisher PS; Jang M; Reddy R; Voegtline K; Olson S; Littlefield K; Park HS; Ursin RL; Ganesan A; Boyer T; Elsayed N; Brown DM; Walch SN; Antar AAR; Manabe YC; Jones-Beatty K; Golden WC; Satin AJ; Sheffield JS; Pekosz A; Klein SL; Burd I
Am J Obstet Gynecol; 2021 Sep; 225(3):301.e1-301.e14. PubMed ID: 33798476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
